Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07360028

Efficacy of Ultrasound Guided Erector Spinae Plane Block Versus Ultrasound Guided Serratus Anterior Plane Block for Postoperative Pain Control Following Video-assisted Thoracoscopic Surgeries (VATS): Randomized Control Trial

The aim of the study is to compare the analgesic efficacy of Erector spinae plane block versus Serratus anterior plane block in patients undergoing video-assisted thoracoscopic surgeries.

Recruiting

Interested in participating?

Request Info

Key information

Age range

25 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ain-Shams University Hospitals

Cairo, Abbassia-Egypt, Egypt

Location status: Recruiting

Location contact

EMAN ZAGHLOUL MADY, MSc

CONTACT

[email protected]

00201013177848

About this study

The aim of the study is to compare the analgesic efficacy of Erector spinae plane block versus Serratus anterior plane block in patients undergoing video-assisted thoracoscopic surgeries.

Preoperative: - On the day before surgery, all patients will be evaluated, detailed medical and surgical history will be taken also physical and systemic examinations will be done.

The following investigations will be done including complete blood count, liver enzymes, prothrombin time, partial thromboplastin time, International normalized ratio (INR) , kidney functions, serum electrolytes and ECG.

All patients will be informed about the visual analogue scale (VAS) on a scale from 0 to 10 where 0 represents no pain and 10 represents the worst imaginable pain.

In the pre-Anesthetic room:

  • baseline hemodynamics will be recorded including heart rate (HR) and mean arterial blood pressure (MAP) and An intravenous access will be inserted.
  • In the operating theatre, full monitors will be applied. Intraoperative: -
  • Fentanyl (1 μg/kg), propofol (2 mg/kg) and atracurium(0.5 mg/kg) will be given IV for general anesthesia induction.
  • Intubation will be done using a double-lumen endobronchial tube size 37 Fr in females and 39 Fr in males, tidal volume will be 6-8 ml/kg in case of both lungs ventilation and 4-6ml/kg during singe lung ventilation.

Anesthesia will continue using isoflurane 2 vol. %, 50% O2 and 50% air.

  • Moreover, three milligrams of Granisetron will be given as prophylactic against nausea and vomiting post-operatively.
  • During operation, 6 mL/kg/h of Ringer's solution will be administered.
  • At the end of surgery, the patient will be positioned laterally.
  • All blocks will be done using ultrasound-guidance (Mindray ultrasound) using high frequency linear probe (10-12 MHZ) by the same experienced senior doctors.

Group A : (25 patients) patients will receive Erector Spinae Plane Block using 20 mL of 0.25% bupivacaine.

Group B: (25 patients) patients will recieve Serratus Aneterior Plane Block using 20 mL of 0.25% bupivacaine.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with American Society of Anesthesiology physical status ASA I, II and III.
  • Patients aged between 25 and 70 years.
  • patients undergoing video-assisted thoracoscopic surgeries (VATS), including pleurectomy, bullectomy, sympathectomy, esophagectomy, decortication, lobectomy, and pneumonectomy.

Exclusion criteria

  • Patients below age of 25 or above age of 70.
  • Patient refusal.
  • Allergy to local anesthetic drugs.
  • Bleeding or coagulation disorder.
  • Psychiatric disorders.
  • Infection at the needle entry site.
  • Renal impairment (creatinine >1.5 ).
  • Hepatic impairment (Child B or C).
  • Patients with known Cortisol related diseases such as Cushing's Syndrome or Addison's Disease.

Treatment and study plan

Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)

Procedure

Ultrasound Guided Erector Spinae Plane block using 20 mL of 0.25% bupivacaine.

Serratus anterior plane block (SAP)

Procedure

Ultrasound Guided Serratus Anterior Plane Block using 20 mL of 0.25% bupivacaine.

Primary outcomes

  1. Visual analogue scale for Assessing postoperative pain control

    Time frame: after ICU admission at 2, 4, 8, 16, 24 hours post operative.

    Assessing The difference in postoperative pain control between both groups as determined by assessing the visual analogue scale

Study contacts

Contact information is provided by the study sponsor or research team.

EMAN ZAGHLOUL MADY, MSc

CONTACT

[email protected]

00201013177848

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jan 22, 2026
Registry last updated
Jan 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.